| Literature DB >> 20851079 |
Jen-Min Huang1, Michela Sali, Matthew W Leckenby, David S Radford, Hong A Huynh, Giovanni Delogu, Rocky M Cranenburgh, Simon M Cutting.
Abstract
Attenuated Salmonella enterica offers a vaccine delivery route that has the benefits of enhanced immunogenicity and oral delivery. The majority of immunization studies have been conducted to deliver recombinant proteins, expressed from a gene that is either chromosomally integrated or carried on a low- or medium-copy number plasmid. There are, however, an increasing number of reports demonstrating the delivery of DNA vaccines, but the high-copy number plasmids that are preferentially used for this application are unstable in Salmonella. Here, we use the Operator-Repressor Titration (ORT) plasmid maintenance system in Salmonella enterica serovar Typhimurium to deliver a high-copy number plasmid expressing the Mycobacterium tuberculosis gene mpt64 to mice. MPT64 expression was detected in phagocytes using immunofluorescence microscopy following Salmonella-mediated delivery of the DNA vaccine. The indicative CD8+ responses measured by antigen-specific IFN-γ were higher from the live bacterial vector than from injected plasmid DNA, and a reduction in the pulmonary bacterial load was seen following an aerogenic challenge. This illustrates the potential of live attenuated Salmonella as oral tuberculosis vaccine vectors.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20851079 DOI: 10.1016/j.vaccine.2010.09.001
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641